This effect is most pronounced in IDH-mutant astrocytomas, in which it acts as an independent prognostic factor, and in some studies has significantly better prognostic utility than current WHO grading schemes, especially when correlating multiple measures of CIN. This evidence concerns the gene IDH2 and astrocytoma (excluding glioblastoma).